Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
If that sounds familiar, you're probably anxious to start losing weight
HEACOCK RA et al
or c) have a BMI between 27 and 30 plus at least one weight-related health condition, such as cardiovascular disease, high blood pressure, or high cholesterol
Eli Lilly's investigational once-weekly injectable the first drug candidate to simultaneously activate GIP, GLP-1, and glucagon receptors posted average weight loss of 28.3% at 80 weeks in TRIUMPH-1, its pivotal Phase 3 obesity trial enrolling 2,339 adults
US$ 26.26
US$ 25.30
US$ 23.68
US$ 21.41
